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Loss of nitric oxide and endothelial derived hyperpolarizing
factor mediated responses in aging.
Background. Aging has considerable structural and func-
tional effects on the vascular system of the kidney. One such
effect is an alteration in vascular tone which potentially will ini-
tiate renal damage. Vascular tone is determined by the balance
between vasoconstrictors and vasodilators. Therefore, we hy-
pothesized that aging attenuates vasodilatory responses in the
kidney. These changes may be mediated by a loss of nitric oxide
and endothelial-derived hyperpolarizing factor (EDHF).
Methods. The systemic and renal responses of nitric oxide and
EDHF were investigated in aging (18 months old) and young
(3 months old) Sprague-Dawley rats.
Results. We demonstrated a general loss of vasodilatory re-
sponses in the aging kidney. In addition, nitric oxide levels were
reduced in the serum and kidney cortex of aging versus young
animals, although this was not accompanied with a loss of en-
dothelial nitric oxide synthase (eNOS) protein in the kidney
cortex. Aging animals also exhibited a loss in EDHF-mediated
vasodilation following stimulation with either acetylcholine or
bradykinin in the isolated perfused kidney.
Conclusion. These findings indicate that not only a defect
in the nitric oxide pathway, but also a loss of EDHF-mediated
responses may be responsible for impaired vasodilation in the
aging kidney. This may result in enhanced vasoconstrictive re-
sponses in aging which potentially will cause renal damage and
ultimately a loss in glomerular filtration rate (GFR).
Aging is a natural process which has considerable struc-
tural and functional effects on the kidney. In aging, re-
nal blood flow is reduced [1, 2] with a parallel decline
in glomerular filtration rate (GFR) from the age of 30
onwards in the adult human [3]. In addition, creatinine
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clearance is decreased by 30% to 40% in individuals over
the age of 80 years and there is an increased prevalence of
microalbumuria [4]. Histologically, both in aging human
and rat renal biopsies focal and segmental glomeruloscle-
rosis develop which is associated with mesangial matrix
expansion and increased basement membrane thicken-
ing [4]. In the tubulointerstitial areas, many tubules be-
come dilated and atrophic accompanied by an increased
degree of interstitial fibrosis and an influx of infiltrating
mononuclear cells [4]. The majority of preglomerular ar-
terioles become thicker [5] and in aging rats a reduction
in glomerular and peritubular capillary number [6, 7] has
also been observed.
It has been hypothesized that one of the key initiating
events leading to renal damage in aging and other pro-
gressive renal diseases is an alteration in vascular tone [8,
9]. The endothelium plays a key role in this process by re-
leasing a variety of relaxing and contracting factors that
regulate the underlying vascular smooth muscle [10]. In
aging humans and animals vasodilatatory responses in-
duced by acetylcholine are attenuated [11–13], while the
responsiveness to vasoconstrictors such as angiotensin II
is enhanced [14, 15]. This may result in enhanced vasocon-
stricitive responses in aging which potentially will cause
renal damage and ultimately a loss in GFR [8, 9].
Two of the most important mediators of vasodilation
are nitric oxide and endothelium-derived hyperpolariz-
ing factor (EDHF). Nitric oxide is formed from the pre-
cursor, L-arginine, through the activity of constitutive and
inducible nitric oxide synthases (iNOS). Total body nitric
oxide production is reduced in aging rats as measured
by the excretion of nitrates and nitrites [16–18] which
also coincides with the progression of renal injury and
decreases in renal plasma flow [16, 17, 19]. In addition,
elevated systemic levels of the endogenous competitive
inhibitor of NOS, NG, NG-asymmetric dimethy-L-argi-
nine (ADMA) are observed in both aging rats and hu-
mans [18, 19]. Decreased expression of endothelial NOS
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(eNOS) and neuronal NOS (nNOS) have been found in
the aging male kidney [7, 20]. The currently unidentified
EDHF initiates vasodilation by the activation of calcium-
induced potassium channels in vascular smooth muscle
cells [21]. In aging, impairment of EDHF-mediated blood
vessel relaxation has been shown in the superior mesen-
teric artery of rats [22] and human gastroepiploic distal
arteries [23]. In addition, studies by Bu¨ssemaker et al [24]
show that renal arterial vessels from old spontaneous hy-
pertensive rats, but not Wistar-Kyoto rats exhibit a total
loss of EDHF-mediated responses.
This study investigated vasodilatory responses in the
aging Sprague-Dawley rat kidney. We hypothesized that
aging would lead to impaired vasodilation mediated by a
loss of nitric oxide and EDHF. Our results demonstrate
that vasodilation is attenuated in the aging kidney and
that alterations in both nitric oxide and EDHF may con-
tribute to this diminished response.
METHODS
Reagents were obtained from Sigma Chemical Co. (St.
Louis, MO, USA) unless otherwise specified.
Animals
Studies were conducted in “old” (18 months old) (N =
7) and “young” (3 months old) (N = 7) adult male
Sprague-Dawley rats (Harlan, Indianapolis, IN, USA).
All animals were fed a standard laboratory diet and water
ad libitium. For determination of protein and creatinine
in the urine, animals were placed in individual metabolic
cages for 24-hour urine collection. During this time, food
was withheld from all animals. Protein concentration was
determined using a commercially available kit (Bio-Rad
Laboratories, Hercules, CA, USA). Creatinine was mea-
sured by reacting urine samples with alkaline picrate to
form a complex whose absorbance could be measured
at 510 nm as according to manufacturer’s instructions
(Diagnostic Chemicals Limited, Oxford, CT, USA). An-
imals were sacrificed and kidneys fixed in either methyl
Carnoy’s solution or periodate-lysine paraformaldehyde
(PLP) for immunohistochemistry or snap-frozen for pro-
tein analysis. For samples snap-frozen the kidneys were
separated into cortex and medulla tissue. Before sacrifice,
serum and plasma was obtained. All animal procedures
were approved by the Animal Care Committee of Baylor
College of Medicine (Houston, TX, USA).
Measurement of nitrites and nitrates
Serum and tissue from the kidney cortex and medulla
of young and old animals were analyzed for nitrites and
nitrates (NO÷) levels. Kidney cortex tissue was first ho-
mogenized in cell lysis buffer (Cell Signaling Technology,
Beverly, MA, USA) and then centrifuged at 13,000×g for
30 minutes. The supernatant was removed and the protein
content was measured with a commercially available kit
(Bio-Rad Laboratories). NO÷ content was determined
by chemiluminescence using a Sievers Instruments Nitric
Oxide Analyzer (Boulder, CO, USA) as previously de-
scribed [25]. In brief, samples were injected into a purge
vessel containing vanadium which converted nitrites and
nitrates into nitric oxide. The nitric oxide was then pro-
pelled by the inert gas nitrogen into a reaction cham-
ber where nitric oxide was oxidized into NO2 by ozone.
The chemiluminescence associated with this reaction was
read in millivolts and recorded as a deflection on a data
recorder. The area under the curve reflected the NO÷
content in the samples. This was read initially as a value
in luminescence units, which when divided by the slope
of a standard curve gave the precise NO÷ content. Ev-
ery sample was measured at least twice. For serum and
tissue levels of NO÷ the measurements were converted
to lmol/L of NO÷/L and lmol/L of NO÷/mg of protein,
respectively.
Immunohistochemistry
Five micrometer frozen sections were cut from the
PLP-fixed tissue. Sections were thawed at room temper-
ature for 2 hours and blocked with 10% fetal calf serum
(FCS), 0.2% bovine serum albumin (BSA), and 0.1%
Tween-20 in phosphate-buffered saline (PBS) (pH 7.4)
for 2 hours at room temperature. Sections were reacted
overnight at 4◦C with mouse antihuman eNOS (1:2000)
(BD Biosciences, Pharmingen, San Diego, CA, USA)
which cross reacts with rat eNOS according to manu-
facturer’s data sheet. Endogenous peroxidase was then
quenched with 0.3% H2O2 in methanol for 30 minutes.
Bound primary antibodies were detected with an En-
Vision kit (Dako, Carpinteria, CA, USA). Brown color
was generated by using a diaminobenzidine (DAB) sub-
strate and nuclei counterstained with hematoxylin. To
determine numbers of macrophages, ED-1 staining was
performed. Five microgram sections were cut from or-
gans fixed in methyl Carnoy’s solution. Sections were
rehydrated and treated with H2O2 and blocking solu-
tion. Sections were reacted overnight with mouse anti-
macrophage ED-1 antibody (1:50) (Serotec, Raleigh, NC,
USA) and bound primary antibodies detected as de-
scribed above. Some sections were also stained with pe-
riodic acid-Schiff (PAS) reagent to evaluate histology.
Negative controls consisted of omission of the primary
antibody or substitution of the primary antibody with the
appropriate preimmune serum. Staining was evaluated in
a blinded manner (N = 5 for young and aging animals).
Western blotting
Fifty micrograms of protein samples prepared as de-
scribed above were denaturated at 100◦C for 5 minutes
and separated on sodium dodecyl sulfate (SDS)-8%
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polyacrylamide electrophoresis gels. Proteins were trans-
ferred to nitrocellulose membranes (Amersham Phar-
macia Biotech, Little Chalfont, Buckinghamshire, UK)
by electroblotting (Bio-Rad Laboratories). Blots were
blocked for 1 hour with 5% (wt/vol) fat-free milk
powder, 0.1% BSA, and 0.1% Tween-20 in PBS, and
incubated with mouse antihuman eNOS (1:1000) anti-
body at 4◦C overnight. Blots were washed in PBS with
0.2% Tween-20 and once in blocking solution. They
were incubated for 30 minutes with second antibodies
and bands detected by chemiluminescence (Amersham
Pharmacia Biotech). Proteins were sized with Rainbow
markers (Amersham Pharmacia Biotech). As a posi-
tive control, protein samples from human umbilical vein
endothelial cells were used. Blots were stripped and
then reprobed for glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) (1:5000) (Abcam, Cambridge, MA,
USA) as a housekeeping gene. The intensities of these
bands was measured by densitometry and analyzed as the
eNOS/GAPDH ratio between aging and young samples
(N = 4 in each group).
Isolated perfused kidney
Isolated perfused kidneys were prepared from ag-
ing and young animals as previously described [26,
27]. Briefly, after anesthesia with peritobarbital sodium
(50 mg/kg intraperitoneally), the left kidney was ex-
posed by midline ventral laparotomy. The left renal
artery was cannulated through the abdominal aorta
and the kidney was perfused by means of a peri-
staltic pump (model 7515-10) (Masterflex Cartridge
Pump) (Cole Parmer Instrument Company, Vernon Hills,
IL, USA) with warmed (37◦C) oxygenated (95% O2
and 5% CO2) Krebs-Henseleit perfusion buffer com-
posed of 118 mmol/L NaCl, 25 mmol/L NaHCO3,
1.9 mmol/L CaCl2, 1.19 mmol/L MgSO4, 4.75 mmol/L
KCl, 1.19 mmol/L KH2PO4, and 11.1 mmol/L dextrose
(pH 7.2). The inferior vena cava was cut to allow the flow
of perfusate and the kidney was removed from the sur-
rounding fat and placed in an organ chamber prewarmed
at 37◦C. Perfusion pressure was monitored constantly
by means of a transducer (Transbridge, model TBM-
4) (World Precision Instrument, Sarasota, FL, USA)
which is connected to a computer by a signal mani-
fold (models DI 720 and DI 205) (DataQ Instruments,
Akron, OH, USA). Renal vascular tone was elevated
by addition of phenylephrine (150 mg/L) to the Krebs
buffer. Acetylcholine and bradykinin (50 to 500 ng) were
injected randomly into the perfusate line proximal to
the kidney and changes in perfusion pressure used as
an index of renal vascular resistance with a decrease
in perfusion pressure indicating vasodilation. To assess
the role of different vasodilator mediators, some ex-
periments were performed with the cyclooxygenase in-
hibitor, indomethacin (10 lmol/L) and a NOS inhibitor,
L-arginine analogue N-nitro-L-arginine methyl ester (L-
NAME) (100 lmol/L) added to the perfusion buffer. In
addition, to analyze the contribution of potassium chan-
nels and epoxyeicosatrienoic acid (EET) to the EDHF
response, some experiments were performed either in the
presence of both apamin (250 nmol/L) and charybdotoxin
(10 nmol/L) or 6-(2-propargyloxyphenyl) hexanoic acid
(PPOH) (30 lmol/L) in the perfusion buffer, respectively.
All responses were measured as the differences between
the basal preconstricted pressure and the peak vasodila-
tory response.
Statistics
Data between aging and young animals were compared
using the nonparametric Mann-Whitney U test, with dif-
ferences being considered significant when P < 0.05. All
values provided are means ± SEM.
RESULTS
General measurements
Studies were performed in both aging (18 months old)
and young (3 months old) rats. Body weight was signifi-
cantly elevated in aging animals (649 ± 42 g) when com-
pared to young animals (237 ± 5 g) (N = 7 in each group)
(P < 0.001). The ratio of 24-hour urine protein/urine cre-
atinine was increased in the aging rats (0.93 ± 0.08 in
aging animals versus 0.733 ± 0.05 in young animals) (P <
0.01).
Microscopic findings in young and aging rats
Sections from aging and young rats were evaluated by
PAS staining to determine morphology (N = 5 from both
aging and young animals). The PAS-stained sections of
kidneys from the young rats showed no abnormalities
in any renal compartment (Fig. 1A). The kidney from
the aging rats showed focal cortical areas with atrophic
tubules, thickened tubular basement membrane, intersti-
tial fibrosis, and interstitial mononuclear inflammatory
cell infiltrates. Focal tubular dilatation with or without
casts were also seen. It should be noted that the chronic
injury involved a small portion (<5%) of the cortex with
the remaining areas displaying no significant changes. The
glomeruli within or adjacent to these areas showed global
or segmental collapse and thickening of the glomeru-
lar basement membrane (Fig. 1B). Immunostaining for
ED-1, a macrophage marker, showed that kidneys from
young animals contained sparse macrophages (Fig. 1C).
In contrast, ED-1–positive cells were prominent in the
areas of chronic tubulointerstitial injury in aging animals
(Fig. 1D).
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Young animals Aging animals
Fig. 1. Histologic observations in the ag-
ing rat kidney. (A) The periodic acid-Schiff
(PAS)-stained sections of kidneys from the
young rats showed no abnormalities in any
renal compartment. (B) The kidney from
the aging rats showed focal cortical areas
with atrophic tubules (∗), thickened tubular
basement membranes (∗), interstitial fibrosis
and interstitial mononuclear inflammatory
cell infiltrates. A glomerulus within the area
of chronic tubulointerstitial injury showed
global collapse and thickening of the glomeru-
lar basement membrane. (C) Kidneys from
young animals contained sparse macrophages.
(D) Macrophages were more prominent in the
areas of chronic tubulointerstitial injury in ag-
ing animals.
Attenuated vasodilation in aging kidneys induced
by acetylcholine
We used the isolated perfused kidney preparation
to determine the renal vasodilatory response to acetyl-
choline. In both young and aging rat kidneys there was
a dose-dependent increase in vasodilation induced by
acetylcholine (N = 5 for each group). Renal vasodilation
tended to be reduced in the aging animals at all doses,
although this was only significant with 50 ng of acetyl-
choline (P < 0.05) (Fig. 2). This data provided a rationale
for further studies investigating the biochemical media-
tors of vasodilation in aging animals.
Nitric oxide measurement in serum and tissue samples
Aging animals had a significantly reduced level of NO÷
in the serum when compared to young animals (16.72 ±
0.3 lmol/L versus 26.6 ± 0.90 lmol/L in young animals)
(P < 0.05) (Fig. 3). Levels of NO÷ in the aging animal
cortex (7.77 ± 0.56 lmol/L of NO÷/mg of protein) were
also significantly reduced when compared to young ani-
mals (19.18 ± 4.55 lmol/L of NO÷/mg of protein) (P <
0.05) (Fig. 4).
eNOS expression in the aging kidney cortex
In young animals, positive staining for eNOS was ob-
served in the glomeruli and in some peritubular capil-
laries (Fig. 5A). Compared to young rats, the kidneys
in aging rats displayed a similar expression of eNOS in
glomeruli but increased expression of eNOS in peritubu-
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Fig. 2. Impairment of vasodilation in the aging rat kidney. Isolated per-
fused kidneys were preconstricted with phenylephrine (PE) and sub-
jected to different doses of acetylcholine (Ach) to elicit vasodilation. In
addition, indomethacin (INDO) was added to the perfusate to block the
contribution of the cyclooxygenase system in these experiments (N =
5 for both young and aging animals at each dose). In both young and
aging rats there was a dose-dependent increase in vasodilation induced
by acetylcholine. There was a tendency for vasodilation to be reduced
in the aging animals at all doses, although this was only significant with
50 ng of acetylcholine. ∗P < 0.05 between young and aging animals.
lar capillaries (Fig. 5B). Staining was not observed using
control nonimmune sera (data not shown). To confirm
the immunostaining findings, Western blotting for eNOS
was performed. Protein levels of eNOS in aging animals
were shown to be up-regulated in the kidney cortex com-
pared to young rats (P < 0.05) (Fig. 6) as assessed by
densitometric analysis.
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Fig. 3. Nitric oxide measurements in rat serum samples. The oxida-
tive end products of nitric oxide (nitrites and nitrates) (NO÷) were
measured by an nitric oxide analyzer that used the vanadium chemilu-
minescence technique in serum samples from young and aging animals
(N = 4 in each group). Each measurement was performed at least twice
and the mean taken as representative of the NO÷ content (lmol/L) (±
SEM). The NO÷ content was significantly reduced. ∗P < 0.05 in the
aging animals when compared to the young rats.
EDHF-mediated responses in the aging rat
The contribution of EDHF to vasodilation in aging was
determined using acetylcholine and bradykinin as ago-
nists in the isolated perfused kidney in the presence of
cyclooxygenase and nitric oxide inhibitors. Both acetyl-
choline and bradykinin induced a dose-dependent in-
crease in vasodilation in both young and aging rats (N =
12 for both young and aging animals). There was a sig-
nificant inhibition (P < 0.05) in vasodilation induced by
acetylcholine and bradykinin in the aging animals indi-
cating an impairment of the EDHF pathway (Fig. 7). The
attenuation of vasodilation in the aging animals tended to
be more marked for responses induced by acetylcholine
than those with bradykinin.
In young animals, the nonselective EET inhibitor,
PPOH significantly impaired vasodilatory responses (P <
0.05) induced by acetylcholine at all doses (Fig. 8A) (N =
7 for young animals with/without PPOH). In aging rats, al-
though there was a tendency for acetylcholine responses
to be impaired with PPOH (Fig. 8B) (N = 3 for aging
animals with/without PPOH) this was not significant and
in some experiments PPOH did not reduce acetylcholine
dilation at all. Vasodilation induced by bradykinin was
attenuated by PPOH in young animals (Fig. 9A) (N =
7 for young animals with/without PPOH). In contrast,
the vasodilatory responses induced by bradykinin in ag-
ing animals were not altered in the presence of PPOH
(Fig. 9B) (N = 7 for aging animals with/without PPOH).
Finally, in both young and aging animals, the potas-
sium channel blockers, apamin and charybdotoxin, signif-
icantly inhibited acetylcholine-induced EDHF-mediated
responses at all doses of agonist used (Fig. 10) (P < 0.05)
(N = 5 in all groups). In addition, EDHF-mediated va-
sodilation in young rats induced by bradykinin was sig-
nificantly inhibited at all doses (Fig. 11A) (P < 0.05)
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Fig. 4. Nitric oxide measurements in the kidney cortex. Nitrites and
nitrates (NO÷) were measured by the vanadium chemiluminescence
technique in kidney cortex tissue samples from young and aging ani-
mals (N = 4 in each group). Measurements were performed at least
twice, the mean taken as representative of the NO÷ content and then
standardized for tissue protein content (lmol/L of NO÷/mg of protein)
(± SEM). In the aging cortex, NO÷ was significantly reduced. ∗P <
0.05 when compared to young rats.
(N = 7 for young animals with/without apamin and
charybdotoxin). In contrast, the bradykinin responses in
aging animals showed no inhibition in the presence of
potassium channel blockers (Fig. 11B) (N = 7 for aging
animals with/without apamin and charybdotoxin)
DISCUSSION
Aging has considerable effects on renal structure and
function in both humans and mammals. While not all
humans show marked structural changes with aging, in
most subjects focal and/or global glomerular sclerosis de-
velops that is characterized by capillary loss, mesangial
explansion, and glomerular basement membrane thick-
ening [28]. Tubulointerstitial fibrosis also occurs, with
tubular atrophy, thickening of tubular basement mem-
branes, and focal areas of interstitial fibrosis and inflam-
mation [28]. The intima of renal arteries becomes thicker
[5], alongside a reduction in glomerular and capillary en-
dothelial cell number [6, 7]. We and others have hypothe-
sized that one of the key initiating events leading to renal
damage in aging may be an alteration in vascular struc-
ture and function [8, 9]. As demonstrated in this study
and others [11–13], the vasodilatory responses induced
by acetylcholine are attenuated in aging animals and
humans.
One important mechanism by which acetylcholine in-
duces vasodilation is by the stimulation of endothelial
cells to release nitric oxide. Nitric oxide induces vascular
smooth muscle relaxation primarily by the activation of
soluble guanylate cyclase, leading to an increase in cyclic
guanosine monophosphate (cGMP), which causes a de-
crease in intracellular calcium ions [29]. The observation
in this study that serum and renal cortical nitrites/nitrates
(which represent the stable end products of nitric oxide
metabolism) were reduced in aging animals is consistent
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Young  animals Aging animals
Fig. 5. Endothelial nitric oxide synthase (eNOS) immunohistochemistry in the aging rat kidney. (A) In young animals, weak staining for eNOS was
observed in the glomerulus and in some peritibular capillaries (arrows). (B) Compared to the young rat, the kidneys of aging rats display a similar
expression of eNOS in glomeruli but an increased expression of eNOS in peritubular capillaries.
with other studies that have reported a loss of nitric oxide
systemically in aging animals [16–18]. The mechanism for
the low systemic nitric oxide levels is complex and may be
due to both decreased synthesis and/or increased degra-
dation [17, 30], although these changes may not translate
to the adult human [31]. A low level of renal nitric oxide
would be expected to result in a reduction in renal blood
flow and an increase in the renal vascular resistance [32].
In addition, aging renal blood vessels tend to be more sen-
sitive to blocking nitric oxide. Vasoconstriction induced
by administration of the nitric oxide inhibitor, L-NAME,
is enhanced in aging renal blood vessels [16, 33]. This sug-
gests that maintaining nitric oxide responses may be more
functionally important in aging renal vessels, perhaps by
compensating for the enhanced vasoconstriction induced
by angiotensin II [14, 15] to maintain vascular tone.
A potential mechanism to explain the nitric oxide re-
duction in the aging kidney is a loss in NOS enzymes. The
main vascular isoform of constitutive NOS is eNOS and
has been implicated in vasodilation induced by acetyl-
choline [34–36]. Therefore, we measured protein levels of
eNOS in the aging kidney. Interestingly, we demonstrated
elevated expression of eNOS by immunohistochemistry
and Western blotting in 18-month-old versus 3-month-
old animals. The role of eNOS protein in the aging rat
kidney is not clear. A study by Adler et al [37] in Fischer
344 male rats showed similar levels of eNOS protein are
present in the renal cortical tissues of young and aging
rats, while others [7, 20] found that eNOS protein is di-
minished in Sprague-Dawley aging animals. It is possible
that the variation in these studies and our data could be
due to rat species or age differences. The animals in our
experiments were 18-month-old rats, whereas a reduction
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Fig. 6. Western blotting for endothelial nitric oxide synthase (eNOS).
(A) Young animals showed faint expression of eNOS protein at the ap-
propriate size of 130 kD. There was an up-regulation of eNOS protein
levels in aging animals. To confirm, the correct size of eNOS protein,
human umbilical vein cells were used as a positive control. (B) Den-
sitometric analysis presented as means ± SD. ∗P < 0.05 for the young
versus aging samples. All signal intensities were compared to levels
of the housekeeping gene, glyceraldehyde-3-phosphate dehydrogenase
(GAPDH). Note the statistically significant up-regulation of eNOS sig-
nal, with regard to the 130 kD band.
in eNOS expression was observed in studies using older
(22 to 24 months old) animals [7, 20]. Intriguingly, we ob-
served a decrease in eNOS mRNA in our animals as de-
termined by real-time polymerase chain reaction (PCR)
[Long DA, Price KL, Johnson RJ, personal observation].
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Fig. 7. Endothelial-derived hyperpolarizing factor (EDHF)–mediated responses in the aging rat. Isolated perfused kidneys were preconstricted
with phenylephrine (PE) and acetylcholine (Ach) and bradykinin (BKN) used as agonists to elicit vasodilation. Indomethacin (INDO) and L-
arginine analogue N-nitro-L-arginine methyl ester (L-NAME) were added to the perfusate buffer to block the contribution of the cyclooxygenase
and nitric oxide pathways, respectively, and therefore assess the role of EDHF (N = 12 for both young and aging animals at each dose). Acetylcholine
(A) and bradykinin (B) induced a dose-dependent increase in vasodilation in both young and aging rats. The vasodilation induced by acetylcholine
and bradykinin was impaired in aging rats. ∗P < 0.05 between young and aging animals.
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Fig. 8. Effect of 6-(2-propargyloxyphenyl) hexanoic acid (PPOH) on acetylcholine (ACh)-induced endothelial-derived hyperpolarizing factor
(EDHF)–mediated responses in young and aging animals. To determine the contribution of epoxyeicosatrienoic acid (EET), acetylcholine-induced
EDHF-mediated vasodilation was measured in young and aging animals in the presence or absence of PPOH. (A) In young animals, PPOH was
able to significantly impair vasodilatory responses by acetylcholine at all doses (N = 7 for animals with/without PPOH). (B) A similar trend was
observed in aging rats but there was no significant difference between the animals with or without PPOH (N = 3 in each group). ∗P < 0.05 between
vasodilatory responses in the presence or absence of PPOH. Abbreviations are: PE, phenylephrine; INDO, indomethacin; L-NAME, L-arginine
analogue N-nitro-L-arginine methyl ester.
It is possible, that with aging there is an initial loss of capil-
laries [6, 7, 38], resulting in tissue hypoxia that stimulates
eNOS expression [39], but that over time there is a loss
of eNOS, first at the mRNA level and then at the protein
level. Therefore, the decrease in eNOS mRNA observed
in our animals may translate into less protein 6 months
later. The alternative possible mechanism to explain this
phenomenon is a change in the stability of mRNA in ag-
ing, altered rates of translation or protein degradation
[40]. There is considerable interest in this area with re-
gard to changes in these processes in aging and this would
be an interesting area for future study.
Our observation that eNOS protein levels are elevated,
but serum nitric oxide is reduced is of interest. The reg-
ulation of nitric oxide production by eNOS is complex,
but the cofactor tetrahydrobiopterin (BH4) plays a key
role [41]. In settings of oxidative stress BH4 can become
oxidized leading to the production of superoxide rather
than nitric oxide [42, 43], a phenomenon known as eNOS
uncoupling [44, 45]. As aging is associated with increased
oxidative stress [46] we could hypothesize that BH4 be-
comes oxidized in aging, leading to the production of su-
peroxide and therefore a loss of nitric oxide, while eNOS
levels are maintained.
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Fig. 9. Effect of 6-(2-propargyloxyphenyl) hexanoic acid (PPOH) on bradykinin (BKN)-induced endothelial-derived hyperpolarizing factor
(EDHF)–mediated responses in young and aging animals. To determine the contribution of epoxyeicosatrienoic acid (EET), bradykinin-induced
EDHF-mediated vasodilation was measured in young and aging animals in the presence or absence of PPOH. (A) In young animals there was a
tendency for PPOH to attenuate the vasodilatory responses induced by bradykinin. There was a significant difference in the responses with/without
PPOH at the dose of 50 and 500 ng of bradykinin (N = 7 with/without PPOH). (B) Vasodilation induced by bradykinin (N = 7 with/without PPOH)
was not altered in aging animals with/without PPOH. ∗P < 0.05 between vasodilatory responses in the presence or absence of PPOH. Abbreviations
are: PE, phenylephrine; INDO, indomethacin; L-NAME, L-arginine analogue N-nitro-L-arginine methyl ester.
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Fig. 10. Effect of potassium channel blockade on acetylcholine (ACh)-induced endothelial-derived hyperpolarizing factor (EDHF)–mediated re-
sponses in young and aging animals. To determine whether potassium channels contributed to the acetylcholine-induced EDHF-mediated responses
in young and aging animals, vasodilation in the isolated perused kidney was measured in the presence and absence of apamin and charybdotoxin.
In both young (A) and aging (B) animals, apamin and charybdotoxin significantly inhibited acetylcholine-induced EDHF-mediates responses at all
doses. ∗P < 0.05 between animals treated with or without apamin and charybdotoxin (N = 5 in each group). Abbreviations are: PE, phenylephrine;
INDO, indomethacin; L-NAME, L-arginine analogue N-nitro-L-arginine methyl ester.
The most novel finding in this study was the demon-
stration that aging rats have a defect in EDHF-like
responses in their renal vasculature. The EDHF-like re-
sponse was investigated by examining the renal vasodila-
tory response induced by acetylcholine and bradykinin in
the isolated perfused kidney model in animals in which
both nitric oxide and prostaglandins were inhibited. Im-
portantly, a marked attenuation in renal vasodilation was
observed in aging rats in response to either acetylcholine
or bradykinin.
There is currently no consensus on the nature of EDHF.
One possibility is that it may be due to several molecules,
including EETs, potassium ions, and H2O2 [47]. To inves-
tigate the role of EETs, we examined the effect of PPOH,
a selective inhibitor of the epoxygneation of arachidonic
acid catalyzed by cytochrome P450 enzymes [48]. PPOH
was able to attenuate EDHF-like responses induced by
bradykinin and acetylcholine in the young rat. However,
this was not the case in aging animals, with no signifi-
cant difference in acetylcholine- or bradykinin-induced
EDHF responses with/without PPOH. This data would
suggest that there may be different EET pathways in-
volved in EDHF-mediated vasodilation in the aging rat
which are not PPOH sensitive.
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Fig. 11. Effect of potassium channel blockade on bradykinin (BKN)-induced endothelial-derived hyperpolarizing factor (EDHF)–mediated re-
sponses in young and aging animals. To determine whether potassium channels contributed to the bradykinin-induced EDHF-mediated responses
in young and aging animals, vasodilation in the isolated perused kidney was measured in the presence and absence of apamin and charybdotoxin.
(A) EDHF-mediated vasodilation in young rats induced by bradykinin was significantly inhibited at all doses. (B) In contrast, the bradykinin
responses in aging animals showed no inhibition in the presence of potassium channel blockers. ∗P < 0.05 between animals treated with or without
apamin and charybdotoxin (N = 7 in each group). Abbreviations are: PE, phenylephrine; INDO, indomethacin; L-NAME, L-arginine analogue
N-nitro-L-arginine methyl ester.
EDHF is also thought to be mediated by potassium
channels. To investigate this possibility, we performed
experiments in the presence of the potassium channel
blockers, apamin and charbyotoxin. Responses medi-
ated by both bradykinin and acetylcholine were blocked
by apamin and charybdotoxin in young animals. Simi-
larly, acetylcholine-induced EDHF vasodilation was also
attenuated by potassium channel blockers, but not re-
sponses induced by bradykinin. This indicates that the
acetylcholine and bradykinin vasodilatory response in the
aging rat are likely to be mediated by two different mech-
anisms, the latter which involves pathways independent
of potassium channels.
There are some important considerations when evalu-
ating the data from these experiments. First, the differ-
ences in serum and tissue NO÷ may partly reflect dietary
intake in aging rats [49]. We can not exclude in our study
the possibility that older rats ate less and hence have
lower NO÷ levels. Second, although many studies have
previously used the isolated perfused kidney to assess
vasodilation [50, 51] there are advantages and disadvan-
tages to this model. An advantage of the isolated perfused
kidney is that one can assess vasodilatory responses of
the whole kidney in a controlled manner without sys-
temic influences. However, a potential disadvantage is
that mediators released from within the kidney, such as
from tubules, may contribute to the EDHF response, and
this needs to be considered when interpreting the results
from these experiments.
CONCLUSION
Our data indicates that there is an impaired renal va-
sodilatory response with aging, and that this involves both
a loss of nitric oxide and EDHF-mediated responses.
The EDHF responses in aging are complex and may in-
volve impairment in both EET-dependent and potassium
channel–dependent pathways. The loss of EDHF and ni-
tric oxide–mediated responses could result in impaired
renal autoregulation, impaired vasodilatory responses,
and therefore potentially higher basal vasomotor tone
and greater sensitivity to vasoconstrictor agents.
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